切换至 "中华医学电子期刊资源库"

中华针灸电子杂志 ›› 2015, Vol. 04 ›› Issue (05) : 249 -251. doi: 10.3877/cma.j.issn.2095-3240.2015.05.014

中医药临床应用

“肺炎消”方促进婴幼儿肺炎恢复期罗音消散疗效观察
郭素香1, 马涛1, 李晓丹1,()   
  1. 1.300150 天津中医药大学第二附属医院儿科
  • 收稿日期:2015-06-30 出版日期:2015-10-15
  • 通信作者: 李晓丹

Effects of “Feiyanxiao” decoction on promoting the recovery of infant pneumonia

Suxiang Guo1, Tao Ma1, Xiaodan Li1,()   

  1. 1.Department of Pediatrics, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150,China
  • Received:2015-06-30 Published:2015-10-15
  • Corresponding author: Xiaodan Li
引用本文:

郭素香, 马涛, 李晓丹. “肺炎消”方促进婴幼儿肺炎恢复期罗音消散疗效观察[J/OL]. 中华针灸电子杂志, 2015, 04(05): 249-251.

Suxiang Guo, Tao Ma, Xiaodan Li. Effects of “Feiyanxiao” decoction on promoting the recovery of infant pneumonia[J/OL]. Chinese Journal of Acupuncture and Moxibustion(Electronic Edition), 2015, 04(05): 249-251.

目的

探讨名老中医任宝成经验方“肺炎消”对婴幼儿肺炎恢复期促进罗音消散的作用。

方法

全部病例来源于2013 年11 月至2014 年3 月就诊于天津中医药大学第二附属医院儿科的肺炎患儿。将83 例肺炎患儿随机分为治疗组42 例和对照组41 例,两组均给予西药常规治疗,治疗组在此基础上予以根据培土生金法拟定的“肺炎消”方治疗。采用SPSS 14.0 统计软件进行统计分析,计数资料用χ2检验,计量资料采用t 检验。

结果

两组临床疗效比较,治疗组42 例,痊愈18 例,好转22 例,无效2 例,总有效率95.24%(40/42);对照组41 例,痊愈17 例,好转17 例,无效7 例,总有效率83.33%(34/41),治疗组疗效优于对照组(χ2=4.12,P<0.01)。两组中医证候比较,治疗组痊愈18 例,好转17 例,愈显率83.80%,对照组痊愈10 例,好转17 例,愈显率66.50%,治疗组优于对照组(χ2=17.97,P<0.05)。

结论

任宝成经验方“肺炎消”能明显促进婴幼儿肺炎恢复期罗音消散,明显改善患儿咳嗽、排痰困难等中医证候,缩短治疗疗程,并能改善患儿的预后,值得临床推广。

Objective

To evaluate the effects of Ren Bao cheng’s "Feiyanxiao” decoction on promoting the recovery of infants pneumonia.

Methods

Eighty-three cases with pneumonia of Second Affiliated Hospital of Tianjin University of traditional Chinese medicine pediatric from November 2013 to March 2014 were selected and then randomly divided into Chinese medicine group (treatment group, n=42)and control group (n=41). The two groups were given conventional Western medicine treatment. The treatment group was given "Feiyanxiao” decoction in addition to the conventional treatment. Statistical method of SPSS14.0 software was used for data analysis. The measurement data was expressed as ±s ,The efficiency was compared using χ 2 test and t-test was used in the comparison between the two groups,Statistically significance was considered when P<0.05.

Results

Compared the clinical efficacy of the two groups,18 cases were cured, 22 cases were improved and 2 cases were ineffective in treatment group, the total effective rate was 95.24% (40/42); 17 cases were cured, 17 cases were improved and 7 cases were invalid,with effective rate of 83.33% (34/41) in control group. The clinical efficacy was much better in treatment group than that of control group (χ2 = 4.12, P<0.01). Traditional Chinese medicine (TCM) syndrome was much better in treatment group (18 cases recovered, 17 cases improved and effective rate was 83.80%) compared with control group (10 cases cured, 17 cases improved and effective rate was 66.50%, χ2=17.97,P<0.05).

Conclusion

“Feiyanxiao” could significantly promote the recovery of infants pneumonia, including the improving difficult cough and expectoration, shortening the treatment course and improving the prognosis.Professor Ren Baocheng’ s clinical experience is worthy of promotion.

表1 两组患儿临床疗效比较(例,%)
表2 两组患儿中医证候积分治疗前后比较(例,%)
[1]
胡亚美,江载芳.诸福棠实用儿科学[M].7 版.北京:人民卫生出版社,2002:1174.
[2]
郑筱萸.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:78.
[3]
徐迪华.中医量化诊断[M].南京:江苏科学技术出版社,1997.
[4]
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
[5]
崔北勇,尹远远.六君子汤在小儿肺炎恢复期的临床应用[J].中医药临床杂志,2009,21(5):424-425.
[6]
薛辉,闫燕.培土生金法治疗小儿肺炎[J].中医研究,1999,12(6):40-41.
[7]
刘薇薇, 张同元, 宫淑琴, 等. 基于“肺- 脾- 大肠”轴的培土生金法干预RRTI 肺脾气虚证患儿唾液sIgA 黏膜免疫研究[J].中国中医基础医学杂志,2014,20(7):948-950.
[1] 张烈, 严一核, 杜洁瑜. 分泌型白细胞蛋白酶抑制因子对无创呼吸机治疗重症肺炎患者的预测效能[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 301-306.
[2] 李世杰, 申传安. 烧伤合并吸入性损伤患者呼吸机相关肺炎的研究现状[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 351-355.
[3] 张胜伟, 孟召路, 热汗古丽·吾休尔, 万世森, 闫鹏, 阳乔. 肺炎支原体诱发反应性感染性皮疹黏膜疹一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 309-313.
[4] 郑宝英, 黄小兰, 贾楠, 朱春梅. 儿童难治性肺炎支原体肺炎早期预警指标[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 215-221.
[5] 徐保平, 彭怀文, 喻怀斌, 王晓涛. 新型冠状病毒肺炎继发糖尿病酮症酸中毒合并肝门静脉积气一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 250-255.
[6] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[7] 晏彦, 杨军, 周凤兰, 孙登昆, 陈玉. 哌拉西林他唑巴坦和哌拉西林舒巴坦治疗细菌性肺炎的倾向性匹配分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 817-819.
[8] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[9] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[10] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[11] 燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[12] 张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[13] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[14] 杨东星, 沈鹏, 赵慧颖. 免疫球蛋白联合依库珠单抗治疗GBS 并发重度ARDS 患者一例[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 404-408.
[15] 段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
阅读次数
全文


摘要